CLX
Get informed when a big investor buys or sells
+ FollowOctober 30, 2024 - AI Summary
Undervalued by 114.7% based on the discounted cash flow analysis.
| Market cap | $9.72 Billion |
|---|---|
| Enterprise Value | $15.10 Billion |
| Dividend Yield | $4.97 (6.18%) |
| Earnings per Share | $4.82 |
| Beta | 0.54 |
| Outstanding Shares | 121,775,000 |
| P/E Ratio | 16.68 |
|---|---|
| PEG | -32.77 |
| Price to Sales | 1.46 |
| Price to Book Ratio | 40.21 |
| Enterprise Value to Revenue | 2.25 |
| Enterprise Value to EBIT | 16.18 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 61.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7577▲ 8.00% |
|---|---|
| Total Calls | 4,051,200▲ 59.34% |
| Total Puts | 3,069,525▲ 78.15% |
Holdings and activity of institutional investors.
| Ownership % | 86.53%▲ 3.87% |
|---|---|
| Total Invested | $10.05B▼ 3.00% |
| Investors Holding | 1,102▼ 28.00% |
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...